The post In first, Israeli doctors deliver gene therapy into brain of 8-month-old baby appeared first on The Times of Israel.

A cutting-edge procedure for treating sickle cell disease is changing lives in the St. Louis area, where an estimated 1,200 ...

An eight-month-old baby from Israel has become the first human ever to receive an experimental gene therapy designed to ...

In the agonizingly slow world of Huntington disease research, hope is usually measured in microscopic increments. So when uniQure announced last year that its investigational gene therapy, AMT-130, ...

The child was one of the first in the world to be treated with gene replacement therapy to restore the function of a crucial ...

Doctors at Clalit-Schneider Children's Medical Center in Israel have performed a world first, injecting a healthy gene ...

Otarmeni, a surgically delivered drug developed by Regeneron, recently received accelerated FDA approval to treat a rare, ...

Onasemnogene abeparvovec-brve is the first gene replacement therapy approved for SMA patients aged 2 years and older, expanding access beyond infants. Phase 3 trials demonstrated significant motor ...

“I was a really, really sick kid,” said Kyle A. Smith, who underwent his first surgery at 3 months old after sickle-cell disease caused blood to become trapped in his spleen. He estimates he has been ...

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss ...

Gene therapy achieved its first major breakthroughs in the early 1990s with the treatment of a rare disease called severe combined immunodeficiency. However, the field was dealt a serious setback in ...